Thiazolidine → HCID 131716935, compound
Reaction equation
[CH:1]1([CH2:10][C:11]([CH:13]2[S:17][CH2:16][NH:15][C@@H:14]2[C:18]([OH:20])=O)=[O:12])[C:9]2[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=2)[CH:3]=[CH:2]1.[NH:21]1[CH2:25][CH2:24][CH2:23][CH2:22]1.C1(CC(C2SCN[C@@H]2C(O)=O)=O)C2C(=CC=CC=2)CC1.S1CCNC1>>[CH:1]1([CH2:10][C:11]([CH:13]2[S:17][CH2:16][NH:15][C@@H:14]2[C:18]([N:21]2[CH2:25][CH2:24][CH2:23][CH2:22]2)=[O:20])=[O:12])[C:9]2[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=2)[CH:3]=[CH:2]1Participants
5
Procedure
Colorless crystals of 1-[3-(2-indenylacetyl)-L-thioprolyl]pyrrolidine were prepared in the same manner as in Example 1, except that 3-(2-indenylacetyl)-L-thioproline prepared in Reference Example 19 and pyrrolidine were used instead of 3-(2-indanylacetyl)-L-thioproline and thiazolidine, respectively (yield: 44%).
Sources & evidence
- ORD record
- ord-8c222dd56d094c369a9dc09cd930bead
- Source dataset
- uspto-grants-1991_07
- Patent number
- US05028604
Reaction notes
Loading…